GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **551 - 575** of **4050** in total

« First

‹ Prev

…

19

20

21

22

23

24

25

26

27

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▼	Arbitrary Fluorescence Units (AFU)
IgG	Patient 2	24	mild	G86156UJ	11808
IgM	Patient 2	15	mild	G86156UJ	284
IgG	Patient 1	6	moderate	G86156UJ	59
IgM	Patient 1	6	moderate	G86156UJ	48
IgA	Patient 2	3	mild	G86156UJ	672
IgG	Patient 2	3	mild	G86156UJ	22997
IgM	Patient 2	24	mild	G86156UJ	331
IgM	Patient 2	3	mild	G86156UJ	527
IgA	Patient 3	-180	mild	G86156UJ	256
IgA	Patient 3	11	mild	G86156UJ	442
IgG	Patient 3	-180	mild	G86156UJ	32
IgM	Patient 3	-180	mild	G86156UJ	52
IgA	Patient 3	4	mild	G86156UJ	474
IgG	Patient 3	11	mild	G86156UJ	66
IgG	Patient 3	4	mild	G86156UJ	67
IgM	Patient 3	11	mild	G86156UJ	71
IgM	Patient 3	4	mild	G86156UJ	78
IgA	Patient 4	12	mild	G86156UJ	421
IgG	Patient 4	12	mild	G86156UJ	83
IgM	Patient 4	12	mild	G86156UJ	94
IgA	Patient 1	10	moderate	G84224TW	358
IgA	Patient 1	22	moderate	G84224TW	325
IgA	Patient 1	6	moderate	G84224TW	312
IgG	Patient 1	10	moderate	G84224TW	27
IgG	Patient 1	22	moderate	G84224TW	36